Results 111 to 120 of about 21,646 (232)

UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays.

PLoS ONE, 2015
IntroductionThe fast, precise, and accurate measurement of the new generation of oral anticoagulants such as dabigatran and rivaroxaban in patients' plasma my provide important information in different clinical circumstances such as in the case of ...
Joachim Kuhn, Tatjana Gripp, Tobias Flieder, Marcus Dittrich, Doris Hendig, Jessica Busse, Cornelius Knabbe, Ingvild Birschmann   +7 more
doaj   +1 more source

Dabigatran Concentrations in an Actively Breastfeeding Mother–Infant Dyad: Extending the Evidence for Oral Thromboprophylaxis Postpartum

American Journal of Hematology, Volume 101, Issue 7, Page 1628-1631, July 2026.
Rasmus W. Green, Aljona Saleh, Pawel Baranczewski   +2 more
wiley   +1 more source

Guidelines for Essential Trauma Care: Second Edition (2026)

World Journal of Surgery, Volume 50, Issue 6, Page 1409-1450, June 2026.
Injury is a major cause of death and disability globally, with the highest burden in low‐ and middle‐income countries (LMICs). Strengthening the organization and planning for trauma care (care of the injured) can improve care and lower mortality. In 2004, the International Association for Trauma Surgery and Intensive Care (IATSIC) and the World Health ...
Charles Mock, Timothy C. Hardcastle, Christine Gaarder, Amit Gupta, Adam Gyedu, Manjul Joshipura, Elmin Steyn, on behalf of the Essential Trauma Care revision author group, Valencia Adjei, Roger Alcock, Vanda Amado, Michael Boampong, Sanjeev Booi, Petra Brysiewicz, Corazon Cabanilla‐Manuntag, Cristiane de Alencar Domingues, Ghada Elhadari, Ranjith Nanda Ellawala, Sarnai Erdene, Ama Akoma Essuman, Jorge Esteban Foianini, Filippo Gatti, Armando Garcia Guererra, Greg Hynes, Adil Haider, Sandy Ingless, Balavenkata Jagannathan, Helen Jowett, Knut Magne Kolstadbråten, Sonja Krofak, Aireen Patricia Madrid, Tina Tomić Mahečić, Claude Martin, Daniel Ntogwrachu, Bisola Onajin‐Obembe, Nhobojit Roy, Andres Rubiano, Niisoja Mensah Torto, Ben Wachira, Meg Walmsley, Torben Wisborg, Elma Wong   +41 more
wiley   +1 more source

Dabigatran effect on bacterial load.

, 2019
A significant reduction in the bacterial load were seen in valves (A), myocardium (B) and spleen (C) in dabigatran (10 mg/kg/b.i.d) compared to saline treated group.
Jens Peter Goetze (316975), Christian J. Lerche (5823854), Lars J. Christophersen (6616250), Kim Thomsen (6616256), Christian Enevold (235168), Niels Høiby (117862), Peter Ø. Jensen (679559), Claus Moser (321011), Pia R. Nielsen (6616253), Henning Bundgaard (441832)   +9 more
core   +1 more source

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

JA Clinical Reports
Background It is difficult to evaluate adequate dose of heparin for cardiopulmonary bypass (CPB) by activated clotting time (ACT) in a patient receiving both heparin and dabigatran because dabigatran can also prolong ACT.
Yu Kawada, Nobuyuki Katori, Keiko Kaji, Shoko Fujioka, Tomoki Yamaguchi   +4 more
doaj   +1 more source

Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation: An Evidence Based Case Report

Majalah Kardiologi Indonesia, 2013
Background. Atrial fibrillation (AF) increases the risk of having stroke as high as five fold. Anticoagulant administration such as vitamin K antagonist has been used regularly to reduce the occurence of stroke.
Alvin Nursalim, Yoga Yuniadi
doaj   +1 more source

Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy

European Journal of Neurology, Volume 33, Issue 6, June 2026.
In this prospective multicenter study, baseline MRI assessed SVD markers and ICAD severity, showing no graded association between ICAD severity and overall SVD burden, although ICAD was linked to more nonlacunar infarcts and fewer PVS. Over a median 2‐year follow‐up, severe‐to‐occluded ICAD independently increased the risk of ischemic events and ...
Kaori Miwa, Masatoshi Koga, Kanta Tanaka, Yusuke Yakushiji, Makoto Sasaki, Kohsuke Kudo, Sohei Yoshimura, Masafumi Ihara, Shigeru Fujimoto, Tadashi Terasaki, Yukako Yazawa, Yoshinari Nagakane, Hiroshi Yamagami, Kazutoshi Nishiyama, Yoshiki Yagita, Shinichi Yoshimura, Teruyuki Hirano, Kazunori Toyoda, BAT2 Investigators   +18 more
wiley   +1 more source

Dabigatran and laboratory tests [Dabigatran e analisi di laboratorio]

, 2015
New oral anticoagulants (i.e., dabigatran, rivaroxaban, apixaban) are now available. In using these drugs, routine monitoring of laboratory coagulation tests is not recommended.
Molon, G, Capizzi, B, Suppi, R, GUIDI, Giancesare, CARUSO, BEATRICE, Negri, M, Facchinetti, R   +6 more
core  

Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive procedures

Transfusion, Volume 66, Issue 6, Page 1203-1209, June 2026.
Abstract Background Oral factor Xa (FXa) inhibitors are anticoagulants with no approved reversal agent for use before urgent invasive procedures. Four‐factor prothrombin complex concentrate (4F‐PCC) is used off‐label for this despite limited evidence regarding its effectiveness and safety.
Mohammad Shamiea, Alex Osnis, Awan Kashoua, Orli Avnery, Gilad Itchaki, Shuli Isman, Tali Tohami, Osnat Jarchowsky‐Dolberg, Martin Ellis   +8 more
wiley   +1 more source

Dabigatran és paraproteinek együttes hatása a thrombin képződésre monoklonális gammopathiákban

Bevezetés: A bizonytalan jelentőségű monoklonális gammopathiát (MGUS) a kóros működésű plazmasejtek felszaporodása okozza. Az állapot kezelést nem igényel, azonban jelentősége, hogy malignus elváltozásba, myeloma multiplexbe (MM) alakulhat át.
Hrenkó, Mátyás
core